Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 5Sarcoma 3Genitourinary 2Gastrointestinal 2Other hematologic neoplasm 1Lymphoid 1Dermatologic 1Classical hematology 1

Conditions

Thrombocytopenia 2Oligodendroglioma 1Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Chronic 1Gliosarcoma 1Glioma 1Glioblastoma 1Ependymoma 1Central Nervous System Neoplasms 1Astrocytoma 1Anemia, Refractory, with Excess of Blasts 1Anemia, Refractory 1

Interventions

sodium thiosulfate 1pegfilgrastim 1etoposide phosphate 1Temozolomide 1Rituximab 1Radiotherapy 1Granulocyte Colony-Stimulating Factor 1Fluorescent Antibody Technique 1Filgrastim 1Etoposide 1Cytarabine 1Cyclophosphamide 1Comparative Genomic Hybridization 1Carboplatin 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Central Nervous System Neoplasms × Amplified Fragment Length Polymorphism Analysis × Classical hematology × Clear all
NCT00471653 2018-07-09

Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Terminated
10 enrolled
CNSClassical hematologySarcoma

Astrocytoma, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Thrombocytopenia, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡